Taclonex Topical Suspension

Generic name: calcipotriene hydrate and betamethasone dipropionate
Dosage form: topical suspension
Drug class:Topical antipsoriatics

Medically reviewed by Drugs.com. Last updated on Oct 22, 2021.

Indications and Usage for Taclonex Topical Suspension

Taclonex® Topical Suspension is indicated for the topical treatment of plaque psoriasis of the scalp and body in patients 12 years and older.

Taclonex Topical Suspension Dosage and Administration

Instruct patients to shake bottle prior to using Taclonex Topical Suspension. Apply Taclonex Topical Suspension to affected areas on the scalp and body once daily for up to 8 weeks. Taclonex Topical Suspension should be discontinued when control is achieved. Instruct patients to wash their hands after applying the product. Inform patients that they should not take a bath or shower or wash their hair right after application of Taclonex Topical Suspension.

Patients 12 to 17 years should not use more than 60 grams per week and patients 18 years and older should not use more than 100 grams per week.

Taclonex Topical Suspension should not be:

• Used with occlusive dressings unless directed by a healthcare provider.
• Used on the face, groin, or axillae, or if skin atrophy is present at the treatment site.
• Applied to the scalp in the 12 hours before or after any chemical treatments to the hair.

Taclonex Topical Suspension is not for oral, ophthalmic, or intravaginal use.

Dosage Forms and Strengths

Topical Suspension: 0.005%/0.064% - each gram contains 50 mcg of calcipotriene and 0.643 mg of betamethasone dipropionate in a viscous, nearly odorless, almost clear, colorless to slightly off-white suspension.

Contraindications

None.

Warnings and Precautions

Hypercalcemia and Hypercalciuria

Hypercalcemia and hypercalciuria have been observed with use of Taclonex Topical Suspension. If hypercalcemia or hypercalciuria develop, discontinue treatment until parameters of calcium metaboli...